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Abstract— In order to reduce motion sickness (MS), a novel 
vibro-motor reprocessing therapy (VRT), based on an Eye 
Movement Desensitization and Reprocessing (EMDR) technique 
is investigated. To the best of the authors knowledge, this is the 
first time that reprocessing therapy has been evaluated for 
alleviating MS. Experimentally, MS was induced using visual 
stimulus of motion videos. Subjective MS was then recorded at 
baseline for both VRT and non-VRT stimulation conditions, and 
after each condition, evaluated using a Motion Sickness 
Assessment Questionnaire (MSAQ). MSAQ scores were 
compared for both conditions in eight test subjects, with a 
significant and clear reduction in motion sickness symptoms 
revealed when applying VRT stimulation. While the subject pool 
is small, this pilot study indicates that the proposed approach 
has potential for future exploration in terms of non-
pharmacological treatment and management of MS. 
I. INTRODUCTION 
Motion sickness is a major issue for the people who are 
prone to the ailment. Approximately 30% of the population is 
naturally immune to motion sickness [1,2] – unfortunately for 
the rest of us, it is a problem that can only be treated, not cured. 
We believe that this problem is set to be exacerbated in future 
with the increasing adoption of autonomous vehicle 
technology in which passengers reportedly feel increased 
sickness when sitting in front but not driving [3]. 
Well-known symptoms of motion sickness are due to 
different kinds of stimuli: travelling by car, plane, train, or in 
space. Some people experience it after chemo treatment [4]. 
Research has found that motion sickness can also be due to 
console-based video games [5]. There exist various forms of 
remedies said to help alleviate motion sickness, ranging from 
looking further into the horizon, keeping eyes closed, napping, 
chewing ginger and acupressure, among others. 
Motion sickness is often thought to manifest itself with 
initial signs and symptoms of nausea and vomiting followed 
by a range of other symptoms. Other symptoms may include 
headache, eyestrain, pallor, sweating, ataxia and vertigo. 
Motion sickness countermeasures can be classified as 
either behavioral or pharmacologic. Pharmacologic measures 
include over-the-counter medications such as those containing 
antihistamines, anticholinergics, and serotonin; and are 
effective at preventing motion sickness. However, most 
current measures do little more than induce drowsiness. 
Behavioral measures could comprise habituation, reprocessing 
or desensitization treatment protocols, among others [6]. The 
purpose of this study is exploring and effectively reducing 
motion sickness/nausea by using non-invasive reprocessing 
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therapy based on alternating vibrating stimulations in both 
palms – this therapy was originally used in psychological 
counselling studies and is based on eye movement. It is 
commonly termed Eye Movement Desensitization and 
Reprocessing (EMDR) [7]. 
II. BACKGROUND 
A. Eye Movement Desensitization and Reprocessing 
This psychotherapeutic technique originated in 1987. The 
technique is a development and research contributed by 
psychologist Francine Shapiro [8]. Since its inception, and 
with no negative side effects, EMDR has found increasing use 
professionally, and is currently being utilized by agencies such 
as the US Departments of Defense and Veterans Affairs [9]. 
Moreover, it is used by governing bodies such as the World 
Health Organization (WHO) [9]. Although it was used initially 
as a treatment towards traumatic memories experienced by 
people, its usage spectrum now includes a variety of disorders 
such as Post-Traumatic Stress Disorder (PTSD) in addition to 
depression, among others [10]. 
Essentially, EMDR therapy works by facilitating 
information processing of traumatic situations or memories 
through adaptive information processing (AIP). Thus, 
previously unprocessed information in the information 
processing system is reprocessed [11]. EMDR treatment 
sessions are lengthy, lasting up to 90 minutes [12] and often 
require repeat sessions. 
The application of EMDR therapy in treating PTSD has 
been recognized as a safe to use psychotherapy choice for 
children, teenagers and adults [13]. Although the use of 
EMDR derivatives, e.g., the vibro-motor reprocessing therapy 
(VRT, as coined by us) in our study, follows procedural 
protocol that differ from those used to treat PTSD, it is a safe 
and mainstream therapy (for example, offered by the National 
Health Service in the UK [14] for other conditions). As a 
benign regimen, it may be particularly useful for children (who 
tend to be more motion-sickness-prone) as well as those with 
other physical and mental health conditions [14].   
B. Visually Induced Motion Sickness 
Visually Induced Motion Sickness (VIMS) can be 
classified as another motion sickness type. It manifests itself 
through nausea (a primary symptom of motion sickness), 
oculomotor strain and disorientation. 
C. Objective 
In this study, we evaluate VRT stimulation response to 
motion sickness induced by VIMS. We focus our analysis on 
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16 motion sickness symptoms activated using a motion video 
visual stimulus. We investigate which motion sickness 
symptoms from the gastrointestinal, central, peripheral and 
sopite-related areas can be suppressed or reduced by VRT 
stimulation, as assessed by a Motion Sickness Assessment 
Questionnaire (MSAQ). The study in [15] validates MSAQ 
efficacy for assessing motion sickness. 
III. METHODOLOGY 
A.  Participants 
A total of eight volunteering participants were invited to 
this study. All participants had perfect or corrected vision. 
Participant cohort were four males and four females, with 
mean age of 29.88 and standard deviation of 12.8 years. 
Participants were asked to give written consent before any 
study-related activity and were eligible to withdraw their 
participation in the study at any given time without providing 
any reason. Only participants fulfilling the inclusion criteria 
were invited to the study. Ethical approval to conduct the study 
was received from the University of Kent Faculty Research 
Ethics Advisory Group for Human Participants (Project 
Identification Reference: 0082021). All the studies performed 
conformed to The Code of Ethics of the World Medical 
Association set by the Declaration of Helsinki. 
B.  Experiment Settings 
This study uses a visual stimulus created as a compilation 
of four shorter videos to build a 10-minute video. The visual 
stimulus induces a spinning-like sensation continuous on a 
spot, to the participant. The full-length video was compiled 
from a personal computer with Adobe Premiere Pro (San Jose, 
USA). The motion video was delivered on a Galaxy S8 
smartphone snapped into Gear Virtual Reality (VR). EMDR 
stimulation was generated through a Tactile Unit plugged into 
a Boka 9 EMDR device (EMDR Equipment Europe, UK). Fig. 
1 shows the EMDR equipment used in this study. 
 
Figure 1.  VRT stimulation unit 
C. Data Acquisition 
The experiment was conducted while participants were 
comfortably seated and visual stimulation presented to them 
using the Gear VR, for both experiment sessions. During the 
VRT stimulation session, participants were asked to rest their 
hands comfortably on their thighs, palms up. The Tactile Unit 
was placed on the palms of the participant to allow for a 
comfortable grip. 
Fig. 2 shows the VRT experimental protocol in this study. 
The experimental procedure included two sessions conducted 
on separate days. The first session was composed of two tasks: 
an eye open task for 5 minutes (baseline) and watching the 
motion video for a possible maximum of 10 minutes or until 
moderate nausea was experienced. The second task was highly 
dependent on the individual participant and their susceptibility 
to motion sickness. As soon as the participant felt 
uncomfortable, the presentation of video stimuli was stopped 
immediately.  
The second session was also composed of two tasks: an eye 
open task for 5 minutes (baseline), then watching the motion 
video while undergoing VRT stimulation simultaneously 
(again for a possible maximum of 10 minutes). Participants 
completed the MSAQ [16] before each baseline task, after 
watching the motion video in session one and after 
simultaneously watching the motion video and undergoing 
VRT stimulation in session two. 
These session types were alternated randomly between the 
participants.  
 
Figure 2.  VRT experimental protocol 
D. Data Analysis 
The MSAQ assesses the severity of exposure to motion 
sickness using a nine-point scale (1 being an experience of ‘not 
at all’ and 9 being ‘severely’) across 16 items. MSAQ contains 
the Gastrointestinal, Central, Peripheral and Sopite-related 
subscales. The final score for motion sickness severity is 
calculated as a percentage of total points obtained: (sum of 
points across all items/144) x 100.  
The percentage of scored points against each factor is 
computed in order to find out the subscale score, thus, we 
calculate the sum of gastrointestinal, central, peripheral and 




respective totals of 36, 45, 27, 36 and finally multiply 
respectively by 100 to obtain a calculated percent of points.  
The MSAQ score can thus range from 11.1% to 100%. An 
MSAQ score of 11.1% indicates that there is no evidence of 
motion sickness whereas a score of 100% concludes to a most 
severe case of motion sickness. 
To explore the changes of MSAQ scores across all four 
subscales and the total correlates of nausea-related and VRT-
related changes in visual stimuli exposure, we computed the 
following metrics within the BASELINE and NAUSEA, and 
BASELINE and VRT analysis windows for each participant. 
The means of MSAQ scores subscales were calculated for all 
participants recorded as fractional changes defined as 
(NAUSEA-BASELINE)/BASELINE and (VRT-
BASELINE)/BASELINE for Gastrointestinal, Central, 
Peripheral and Sopite-related. Non-parametric statistical tests 
were used to analyze the data, since normality of data was not 
assumed. Statistical analysis was carried out using MATLAB 
R2020b (MathWorks Inc., USA). 
IV. RESULTS AND DISCUSSION 
A total of eight participants were included in the study with 
no dropouts. All participants completed the study without 
vomiting. Despite the small sample size, the results of the 
study were consistently in the same direction. Based on the 
MSAQ scores, the motion video provoked visually induced 
motion stimulus (VIMS) of at least 20% and a mean score of 
37.5% across all participants.  
All participants were symptomatic, i.e., participants 
reporting at least one symptom from a collection of the 16 
symptoms that are in the MSAQ. Some of the participants 
reported mild cases of headache after the experiment 
conducted without the VRT stimulation. After the VRT 
stimulation, by contrast, the same participants reported no mild 
discomfort of any sort. 
TABLE I.  COMPARISON OF MSAQ SCORES IN TWO CONDITIONS 
Participant Gender 







P1 F 38 21 17 
P2 M 42 26 16 
P3 M 50 15 35 
P4 M 20 13 7 
P5 M 59 20 39 
P6 F 22 20 2 
P7 F 23 14 9 
P8 F 46 38 8 
Average 37.5 20.9 16.6 
 
MSAQ scores between with VRT and without VRT 
conditions across the four subscales (gastrointestinal, central, 
peripheral, sopite-related) and total score were compared for 
the effectiveness of VRT stimulation as shown in Table I and 
Fig. 3. It can be seen from Fig. 3 that there is a significant drop 
for the Sopite category. Research has found a relationship 
between motion sickness and drowsiness (so-called sopite 
syndrome) [17]. There was an improvement of at least 2% on 
the MSAQ total score (with average of 16.6%) for experiments 
conducted with respect to VRT stimulation scores across the 
participants. Participant 5 had the highest improvement of 
39% - this was the participant that felt very uncomfortable 
without VRT and stopped the motion video early on (around 5 
minutes) but lasted until the end with VRT (i.e. 10 minutes) 
without any discomfort. 
It can also be seen that median values for each subscale and 
total MSAQ scores for the VRT stimulation session were 
lower than for the non-VRT session. It is also evident that the 
range of the data for the VRT session was much reduced 
compared to the non-VRT session, as shown in Fig. 3. This 
indicated that VRT consistently reduced motion sickness 
symptoms for all participants.  
 
Figure 3.  Average MSAQ score for with and without VRT stimulation 
 
Figure 4.  MSAQ scores for the four categories; Gastrointestical, Central, 
Peripheral, and Sopite against participant age in two conditions 
Differences in the totals of the scores between the two 




number of participants. However, the symptoms of motion 
sickness from the two conditions were significantly different. 
A Wilcoxon signed rank test indicated sufficient statistical 
evidence to conclude that the median MSAQ scores (using 
scores from all the four categories) after VRT stimulation were 
less than the median MSAQ scores without VRT stimulation 
(p = 0.0078). 
Fig. 4 displays the relationship between participants’ ages 
and severity of motion sickness symptoms. As can be seen 
from the figure, older participants showed a greater range of 
values in the subscales compared to younger participants. It 
can also be seen that the use of VRT reduced this range for all 
participants, thereby indicating positive effects irrespective of 
age, although a larger sample size is required before this effect 
can be conclusively demonstrated. 
 
Figure 5.  QQ Plot of MSAQ scores across the four subscales for all 
participants 
Fig. 5 shows the quantile-quantile plot for the MSAQ 
scores across the four subscales for all the participants. It can 
be seen that without VRT, the distribution was normal. The 
VRT conditions were positively skewed showing that most of 
the MSAQ scores were smaller among the participants. The 
lower slope with VRT shows that the standard deviation of the 
scores was smaller as compared to without VRT, again 
illustrating consistent values for all participants.  
V. CONCLUSION 
In this study, we have demonstrated that motion sickness 
symptoms can be reduced through VRT stimulation – a non-
pharmacological, portable and easy to apply treatment. 
Motion sickness was induced visually in eight volunteers, 
using a VR headset. VRT stimulation was applied using Boka 
9 Tactile Unit EMDR equipment, and motion sickness 
symptoms were assessed by MSAQ. Despite the small sample 
size, VRT led to a statistically significant reduction in 
symptoms.  
In future, we plan to investigate these effects using a larger 
number of participants, and further study the positive effects 
of VRT stimulation in reducing motion sickness symptoms 
induced by VIMS. Furthermore, VRT demands further 
investigation to understand how it causes these physiological 
changes. Research has studied psychophysiological changes 
concurrent with VIMS, using a motion video, theorizing 
evident statistical differences between participants 
developing nausea compared to ones who do not [16]. Our 
future research will extend to analysis of such psychological 
measures repeated over multiple sessions.  
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